SCHEMBL4284968

SCHEMBL4284968

C=CCc1ccc(OC(=O)c2ccccc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 12/20 0.62
MEN1 O00255 5/20 0.62
TDP1 Q9NUW8 3/20 0.62
L3MBTL1 Q9Y468 2/20 0.62
CYP3A4 P08684 2/20 0.62
PARP10 Q53GL7 1/20 0.54
MAPT P10636 6/20 0.53
RAB9A P51151 1/20 0.53
ALDH1A1 P00352 4/20 0.51
PKM P14618 1/20 0.51
SRD5A1 P18405 1/20 0.49
PTPN1 P18031 1/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
TP53 P04637 1/20 0.47
ALOX15 P16050 1/20 0.47
TSHR P16473 1/20 0.47
ALOX12 P18054 1/20 0.47
KDM4E B2RXH2 2/20 0.47
GAA P10253 1/20 0.47
HPGD P15428 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11013802 0.94 KMT2A (0.58) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9297822 0.92 CYP3A4 (0.52) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9302944 0.91 KMT2A (0.53) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9304692 0.91 KMT2A (0.53) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL22171676 0.89 KMT2A (0.53) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9734037 0.86 MEN1 (0.49) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9736464 0.86 CYP3A4 (0.47) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9736600 0.86 MEN1 (0.49) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL9734980 0.86 CYP3A4 (0.47) KMT2AMEN1TDP1L3MBTL1CYP3A4
SCHEMBL11378484 0.85 CYP3A4 (0.50) KMT2AMEN1TDP1L3MBTL1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-53003979-A None JP disclosed
US-20090169494-A1 Sunscreen cosmetic composition SHISEIDO COMPANY LTD (JP) 2009-07-02 US disclosed
EP-1944012-A1 SUNSCREEN COSMETIC COMPOSITION Shiseido Company, Limited (JP) 2008-07-16 EP disclosed
US-5575958-A HYDROXYPHENYL TRIAZINES CIBA-GEIGY CORPORATION (US) 1996-11-19 US disclosed
US-5009669-A Aqueous dispensions of 2-(2'-hydroxyphenyl)benzotriazoles CIBA-GEIGY CORPORATION (US) 1991-04-23 US disclosed
US-4831068-A PHENYL-S-TRIAZINE DERIVATIVES AS UV ABSORBERS CIBA-GEIGY CORPORATION (US) 1989-05-16 US disclosed
US-4456668-A DYE BLEACH, TEXTILE DYES CIBA GEIGY AG (CH) 1984-06-26 US disclosed
US-4409143-A TEXTILES, PHOTOGRAPHY CIBA-GEIGY AG (CH) 1983-10-11 US disclosed
US-4082428-A AROMATIC ESTERS SUNCRUX INCORPORATED (US) 1978-04-04 US disclosed
US-4082428-A AROMATIC ESTERS SUNCRUX INCORPORATED (US) 1978-04-04 US disclosed
JP-S533979-A LIQUID CRYSTAL COMPOSITION DAINIPPON TORYO CO LTD 1978-01-14 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090169494-A1 Sunscreen cosmetic composition SUN2, TYR, AHR KMT2A 981/4885MEN1 2821/4885TDP1 1947/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.